IRIS
PACINI, FURIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.894
EU - Europa 6.751
AS - Asia 2.726
SA - Sud America 581
AF - Africa 61
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 19.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.828
GB - Regno Unito 2.185
CN - Cina 1.216
IE - Irlanda 927
RU - Federazione Russa 775
SG - Singapore 772
IT - Italia 738
UA - Ucraina 560
SE - Svezia 506
BR - Brasile 493
DE - Germania 352
FR - Francia 283
HK - Hong Kong 249
FI - Finlandia 187
KR - Corea 157
VN - Vietnam 112
NL - Olanda 69
IN - India 54
TR - Turchia 41
AR - Argentina 32
ES - Italia 32
CA - Canada 31
BE - Belgio 29
BD - Bangladesh 24
MX - Messico 24
PL - Polonia 22
ZA - Sudafrica 21
AT - Austria 16
JP - Giappone 16
PY - Paraguay 13
VE - Venezuela 13
MA - Marocco 12
AU - Australia 11
IQ - Iraq 11
CZ - Repubblica Ceca 10
CL - Cile 9
EU - Europa 8
UZ - Uzbekistan 8
BG - Bulgaria 7
CO - Colombia 7
EC - Ecuador 7
IR - Iran 7
CH - Svizzera 6
CI - Costa d'Avorio 6
JO - Giordania 6
KE - Kenya 6
RO - Romania 6
GR - Grecia 5
IL - Israele 5
LT - Lituania 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
PT - Portogallo 5
AL - Albania 4
BO - Bolivia 4
EE - Estonia 4
HU - Ungheria 4
ID - Indonesia 4
NP - Nepal 4
OM - Oman 4
SA - Arabia Saudita 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CY - Cipro 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
UY - Uruguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CU - Cuba 2
DK - Danimarca 2
LV - Lettonia 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
PH - Filippine 1
QA - Qatar 1
SN - Senegal 1
TM - Turkmenistan 1
Totale 19.036
Salva come PNG Salva come JPEG
Città #
Southend 2.032
Fairfield 1.252
Dublin 909
Dallas 852
Ashburn 633
Woodbridge 591
Chandler 581
Wilmington 474
Seattle 465
Jacksonville 451
Houston 441
Santa Clara 429
Cambridge 407
Beijing 340
Singapore 313
Ann Arbor 290
Siena 279
Hong Kong 243
Seoul 154
Nanjing 153
Moscow 150
Princeton 149
Hefei 131
Los Angeles 111
Boardman 81
Helsinki 77
Munich 66
San Diego 64
Dong Ket 56
Nanchang 55
New York 53
Buffalo 47
Amsterdam 43
San Mateo 41
Saint Petersburg 40
São Paulo 40
Düsseldorf 36
Milan 36
Council Bluffs 34
London 34
Florence 31
Shanghai 31
Tianjin 31
Turku 30
Shenyang 29
Brussels 27
Kunming 27
Jiaxing 26
Lancaster 26
Chicago 24
Hebei 24
Changsha 23
Columbus 23
Guangzhou 22
The Dalles 22
Washington 22
Izmir 21
Jinan 20
Prato 20
Dearborn 19
Ho Chi Minh City 19
Norwalk 18
Redondo Beach 18
Redwood City 18
Zhengzhou 17
Málaga 15
Ningbo 15
Denver 14
Hanoi 14
Rome 14
San Francisco 14
Tokyo 14
Warsaw 14
Belo Horizonte 13
Brooklyn 13
Phoenix 13
Renton 13
Brasília 12
Montreal 12
Venezia 12
Johannesburg 11
Rio de Janeiro 11
East Falmouth 10
Stockholm 10
Vienna 10
Ankara 9
Atlanta 9
Hangzhou 9
Menlo Park 9
Nuremberg 9
Bengaluru 8
Boston 8
Chennai 8
Toronto 8
Campinas 7
Caxias do Sul 7
Curitiba 7
Frankfurt am Main 7
Guarulhos 7
Naples 7
Totale 13.594
Salva come PNG Salva come JPEG
Nome #
null 398
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 331
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer 326
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 289
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 282
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 275
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 272
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 263
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 260
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 247
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 246
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer 242
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 241
Approach to and treatment of differentiated thyroid carcinoma 239
Reference range of serum calcitonin in pediatric population 236
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 236
Acute exogenous TSH administration stimulates leptin secretion in vivo 235
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 229
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma 223
Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB) 221
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 216
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question 214
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 210
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 210
Definition and management of radioactive iodine-refractory differentiated thyroid cancer 209
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 208
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update 207
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab 206
Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer 206
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment 202
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 200
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancer 200
Management of papillary thyroid microcarcinoma: primum non nocere! 197
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone 197
Management of thyroid nodules: a clinicopathological, evidence-based approach 196
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 196
Changing natural history of differentiated thyroid cancer 195
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 192
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 192
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 189
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 185
Ernest L. Mazzaferri, MD, MACP (1936-2013) 185
Medullary thyroid carcinoma 183
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up 183
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 182
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 182
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 181
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 178
H. pylori (hp) infection and autoimmune diseases (ad): prevalence of infection in patients with Hashimoto's thyroiditis (ht) and allignement of thyroid hormones (th) with H. pylori proteins. 175
Serum Ghrelin As a Marker of Atrophic Body Gastritis in Patients With Parietal Cell Antibodies 174
Screening of thyroid nodules by serum calcitonin measurements: why not? 173
Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients 171
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 168
Management of differentiated thyroid cancer of the follicular epithelium 167
Observation for newly diagnosed micro-papillary thyroid cancer: is now the time? 166
Post-thyroidectomy chronic asthenia: self-deception or disease? 165
Multinodular goiter of unusual shape and location 164
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 164
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 164
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 163
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 163
Best practice & research clinical endocrinology & metabolism. Thyroid nodules and cancer. Preface 162
Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer 162
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology 161
Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis 160
Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions 159
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 158
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal 157
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 157
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? 156
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 155
Telomeres and thyroid cancer 154
How Far Should We Go in the Search and Treatment of Recurrent or Persistent Lymph Node Metastases during Follow-Up of Thyroid Cancer Patients? 154
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 153
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 152
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 151
The low utility of pretherapy scans in thyroid cancer patients 149
Management of advanced medullary thyroid cancer 149
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study 147
Targeted therapy in refractory thyroid cancer: current achievements and limitations 146
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 146
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis 145
Rare diseases in clinical endocrinology: a taxonomic classification system 143
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer 143
New insight in the follow-up strategies of differentiated thyroid cancer 140
Down modulation of IG20/MADD expression or phosphorylation renders TRAIL resistant thyroid cancer cells susceptible to TRAIL treatment 136
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 135
Thyroid microcarcinoma 135
Medullary thyroid cancer: management guidelines of the American Thyroid Association 134
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 134
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 131
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 130
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration 127
Radioiodine therapy in the different stages of differentiated thyroid cancer 126
null 126
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 125
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 123
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer 120
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium 116
Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian Syndrome 115
Totale 18.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.138
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.687 0 0 0 0 141 289 133 372 177 232 161 182
2021/20221.276 132 183 70 97 68 52 62 41 82 142 141 206
2022/20231.937 114 172 258 268 193 380 38 169 212 32 72 29
2023/20241.250 67 30 106 39 52 351 458 19 6 18 16 88
2024/20252.846 56 138 243 139 388 197 96 143 238 97 396 715
2025/20263.015 528 912 627 728 220 0 0 0 0 0 0 0
Totale 19.230